Firstline treatment with ruxolitinib versus best available therapy in patients with polycythemia vera: results from the randomized RuxoBEAT trial. [PDF]
Koschmieder S +27 more
europepmc +1 more source
Ropeginterferon dose-escalation strategies in polycythemia vera: a systematic review and meta-analysis. [PDF]
Yoon SY +7 more
europepmc +1 more source
NGS and emerging molecular scenarios in chronic myeloproliferative neoplasms: a case of double mutated polycythemia vera. [PDF]
Cerchiara E +9 more
europepmc +1 more source
Prevalence, incidence, and risk factors of secondary malignancies in patients with polycythemia vera: a real-world study. [PDF]
Pemmaraju N +11 more
europepmc +1 more source
Polycythemia Vera with Incidental Large Aortic Aneurysm and Giant Cell Arteritis: Case Report. [PDF]
Obaid K +8 more
europepmc +1 more source
JAK Inhibitor-Induced Improvement of IgA Nephropathy in a Patient With Polycythemia Vera: A Case Report. [PDF]
Takahashi-Kobayashi M +5 more
europepmc +1 more source
Acute Finger Ischemia Evaluated With Point-Of-Care-Ultrasound and Diagnosed With Concurrent Polycythemia Vera, Antiphospholipid Syndrome, and Tobacco Use. [PDF]
Burgess T, Larkins MC, Chu T.
europepmc +1 more source
Cardioembolic ST-Elevation Myocardial Infarction in a Patient With Atrial Fibrillation and Polycythemia Vera. [PDF]
Acharya S +5 more
europepmc +1 more source
Optimizing Polycythemia Vera Management Through a Collaborative Care Model Between Leukemia Oncologists and an Integrated Specialty Pharmacy. [PDF]
Yogarajah U +7 more
europepmc +1 more source

